By Business/Source
Currency:USD
2026/Q2
Stock NameRevenueRatio
Discovery, development and commercialization of medicines and technologies1.57M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United Kingdom29.05M100.00%